npj Parkinson s DiseaseNeurosciencePeer-reviewed journal article
Protection from α-synuclein-induced dopaminergic neurodegeneration by overexpression of the mitochondrial import receptor TOM20 in the rat midbrain
Briana R. De MirandaiD, Emily M. RochaiD, Sandra L. CastroiD, J. Timothy GreenamyreiD
Abstract
Dopaminergic neurons of the substantia nigra are selectively vulnerable to mitochondrial dysfunction, which is hypothesized to be an early and fundamental pathogenic mechanism in Parkinsons disease (PD). Mitochondrial function depends on the successful import of nuclear-encoded proteins, many of which are transported through the TOM20-TOM22 outer mitochondrial membrane import receptor machinery. Recent data suggests that post-translational modifications of -synuclein promote its interaction with TOM20 at the outer mitochondrial membrane and thereby inhibit normal protein import, which leads to dysfunction and death of dopaminergic neurons. As such, preservation of mitochondrial import in the face of -synuclein accumulation might be a strategy to prevent dopaminergic neurodegeneration, however, this is difficult to assess using current in vivo models of PD. To this end, we established an exogenous co-expression system, utilizing AAV2 vectors to overexpress human -synuclein and TOM20, individually or together, in the adult Lewis rat substantia nigra in order to assess whether TOM20 overexpression attenuates -synuclein-induced dopaminergic neurodegeneration. Twelve weeks after viral injection, we observed that AAV2-TOM20 expression was sufficient to prevent loss of nigral dopaminergic neurons caused by AAV2-Syn overexpression. The observed TOM20-mediated dopaminergic neuron preservation appeared to be due, in part, to the rescued import of nuclear-encoded mitochondrial electron transport chain proteins that were inhibited by -synuclein overexpression. In addition, TOM20 overexpression rescued the import of the chaperone protein GRP75/mtHSP70/mortalin, a stress-response protein involved in -synuclein-induced injury. Collectively, these data indicate that TOM20 expression prevents -synuclein-induced mitochondrial dysfunction, which is sufficient to rescue dopaminergic neurons in the adult rat brain.
- Citations
- 38
- FWCI
- 2.06
- Field percentile
- top 10%
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Modulation of SLP-2 expression protects against alpha-synuclein neuropathology by mitigating mitochondrial dysfunction
Cyril Bolduc, Maria Paulina Castelo Rueda, … Martin Lévesque·bioRxiv·Jun 13, 2025
- Viral overexpression of human alpha-synuclein in mouse substantia nigra dopamine neurons results in hyperdopaminergia but no neurodegeneration
Sofia Ines Garcia Moreno, Fabian Limani, … Thomas Steinkellner·Experimental NeurologyPeer-reviewed·Sep 15, 2024
- VMAT2 dysfunction impairs vesicular dopamine uptake, driving its oxidation and α-synuclein pathology in DJ-1-linked Parkinson's disease neurons
Leonie M. Heger, Francesco Gubinelli, … Lena F. Burbulla·Science AdvancesPeer-reviewed·Feb 11, 2026
- α-Synuclein impairs mitochondrial function and alters cryptochrome regulation in the substantia nigra
Sinéad A. O’Sullivan, Adrian Perdyan, … Donato A. Di Monte·bioRxiv·Aug 21, 2026
- Novel insights in the pathophysiology of α-synuclein dysregulation on D2 receptor activity contributing to the vulnerability of dopamine neurons
Abeer Dagra, Douglas R. Miller, … Habibeh Khoshbouei·bioRxiv·Mar 30, 2021
- Alpha-Synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinsons disease
Fanni F. Geibl, Martin T. Henrich, … Dalton James Surmeier·Molecular NeurodegenerationPeer-reviewed·Oct 8, 2024